Literature DB >> 22843950

Effect of serum selenium levels on radiotherapy-related toxicity in patients undergoing radiotherapy for head and neck cancer.

Celalettin Eroglu1, Dilek Unal, Aysun Cetin, Okan Orhan, Serdar Sivgin, Ahmet Oztürk.   

Abstract

AIM: To investigate whether there is a difference in selenium levels before and after radiotherapy (RT) and to study the effects of serum selenium levels on RT-related toxicity in patients undergoing RT for head and neck cancer. PATIENTS AND METHODS: A population of 47 consecutive patients was enrolled in the study. RT was given by conventional fractionation. RT-related acute toxicity was evaluated once a week. Blood samples were obtained before and after RT to evaluate selenium levels.
RESULTS: There was no significant difference between the levels of selenium before and after RT (58.09 ± 1.36 μg/l and 56.34 ± 1.11 μg/l, p-value=0.747, respectively). Grade III-IV mucositis, dysphagia, radiodermatitis, and nausea were seen in 6 (12.7%), 32 (68.2%), 24 (51.1%), and 3 (6.4%) patients, respectively. It was found that there was no statistically significant difference in the levels of selenium before and after RT, and no observed differences in regard to RT-related toxicities.
CONCLUSION: The serum selenium levels do not affect RT-related toxicities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843950

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.

Authors:  Michael Mix; Anurag K Singh; Michael Tills; Shiva Dibaj; Adrienne Groman; Wainwright Jaggernauth; Youcef Rustum; Michael B Jameson
Journal:  World J Clin Oncol       Date:  2015-10-10

2.  Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer.

Authors:  Michael Mix; Nithya Ramnath; Jorge Gomez; Charles de Groot; Saju Rajan; Shiva Dibaj; Wei Tan; Youcef Rustum; Michael B Jameson; Anurag K Singh
Journal:  World J Clin Oncol       Date:  2015-10-10

3.  Protective Effects of IMOD and Cimetidine against Radiation-induced Cellular Damage.

Authors:  S Rahgoshai; M Mohammadi; S Refahi; M Oladghaffari; S M R Aghamiri
Journal:  J Biomed Phys Eng       Date:  2018-03-01

Review 4.  Updates on clinical studies of selenium supplementation in radiotherapy.

Authors:  Irma M Puspitasari; Rizky Abdulah; Chiho Yamazaki; Satomi Kameo; Takashi Nakano; Hiroshi Koyama
Journal:  Radiat Oncol       Date:  2014-05-29       Impact factor: 3.481

Review 5.  A Comprehensive Review on Selenium and Its Effects on Human Health and Distribution in Middle Eastern Countries.

Authors:  Marek Kieliszek; Iqra Bano; Hamed Zare
Journal:  Biol Trace Elem Res       Date:  2021-04-21       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.